By Hannah Albarazi ( May 15, 2019, 9:45 PM EDT) -- Ixchel Pharma LLC urged the Ninth Circuit at a hearing Wednesday to revive allegations that Biogen Inc. illegally undermined its development of a neuromuscular disease treatment by signing an anti-competitive deal with another company, arguing that California's legal restrictions on noncompetes should protect corporations, not just individual people....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.